XenoPort Email Formats

Pharmaceutical Manufacturing • United States • 101-200 Employees

XenoPort Email Formats

XenoPort uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 51.3% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	51.3%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	21.8%
{first name}@company.com	john@company.com	11.2%
{last name}.{first name}@company.com	doe.john@company.com	9.1%
{first name}_{last name}@company.com	john_doe@company.com	6.6%

Key Contacts at XenoPort

Julie Morrison

Regional Sales Director

Joe Fernandez

National Account Director

Sam Iki

Sr. Director, Project Management

Janet Hurt

Sr. Director, Clinical Operations

Gorm Yoder

Associate Director - Analytical Chemistry

Marzena Chogwska

Owner

Michele Britton

Associate Director, Clinical Operations

Drew Jones

Senior Medical Director

Thamil Annamalai

Director

Joe Ferraro

Regional Sales Director

Company overview

Headquarters	United States
Phone number	+14086167200
Website	xenoport.com
NAICS	3254
Founded	1999
Employees	101-200
Socials

About XenoPort

XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regnite® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astellas Pharma Inc. XenoPort holds all other world-wide rights to gabapentin enacarbil. XenoPort's pipeline of product candidates includes potential treatments for patients with Parkinson's disease, relapsing-remitting multiple sclerosis and psoriasis.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Entry

Senior

Director

Employees by Department

XenoPort has 48 employees across 12 departments.

Departments

Number of employees

Funding Data

Explore XenoPort's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2012-12-21	14	$20,000,000

Funding Insights

$20,000,000

Total funding amount

$20,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

XenoPort is located in US.

You can reach XenoPort at +14086167200.

XenoPort was founded in 1999, making it 27 years old. The company has established itself as a significant player in its industry over this time.

XenoPort has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

XenoPort has raised a total of $20,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at XenoPort

Julie Morrison

Regional Sales Director

Joe Fernandez

National Account Director

Sam Iki

Sr. Director, Project Management

Janet Hurt

Sr. Director, Clinical Operations

Gorm Yoder